Literature DB >> 8325993

Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitus.

N M O'Meara1, J Sturis, E Van Cauter, K S Polonsky.   

Abstract

Normal subjects demonstrate the presence of ultradian oscillations (period 80-150 min) in insulin secretion rate (ISR) tightly coupled to glucose oscillations of similar period. These oscillations appear to be a function of the feedback loop linking glucose and insulin. The present study was undertaken to determine whether the control by glucose of the ultradian oscillations in insulin secretion is altered in impaired glucose tolerance IGT and in non-insulin-dependent diabetes mellitus (NIDDM). Patients with NIDDM (n = 7), IGT (n = 4), and matched nondiabetic controls (n = 5) were studied under three separate protocols that involved administration of glucose at either a constant rate of 6 mg/kg per min for 28 h or in one of two oscillatory patterns at the same overall mean rate. The amplitude of the oscillations was 33% above and below the mean infusion rate, and their respective periods were 144 min (slow oscillatory infusion) or 96 min (rapid oscillatory infusion). Insulin, C-peptide, and glucose were sampled at 10-min intervals during the last 24 h of each study. ISRs were calculated by deconvolution of C-peptide levels. Analysis of the data showed that (a) the tight temporal coupling between glucose and ISR in the nondiabetic controls was impaired in the IGT and NIDDM groups as demonstrated by pulse analysis, cross-correlation analysis, and spectral analysis; (b) the absolute amplitude of the ISR pulses progressively declined with the transition from obesity to IGT to NIDDM; and (c) the absolute amplitude of the ISR oscillations failed to increase appropriately with increasing absolute amplitude of glucose oscillations in the IGT and NIDDM subjects compared with the control group. In conclusion, the present study demonstrates that important dynamic properties of the feedback loop linking insulin secretion and glucose are disrupted not only in established NIDDM but also in conditions where glucose tolerance is only minimally impaired. Further studies are needed to determine how early in the course of beta-cell dysfunction this lack of control by glucose of the ultradian oscillations in insulin secretion occurs and to define more precisely if this phenomenon plays a pathogenetic role in the onset of hyperglycemia in genetically susceptible individuals.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8325993      PMCID: PMC293585          DOI: 10.1172/JCI116560

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  Estimating false-positive and false-negative errors in analyses of hormonal pulsatility.

Authors:  E Van Cauter
Journal:  Am J Physiol       Date:  1988-06

2.  Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  N Yoshioka; T Kuzuya; A Matsuda; M Taniguchi; Y Iwamoto
Journal:  Diabetologia       Date:  1988-06       Impact factor: 10.122

3.  Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance.

Authors:  W K Ward; E C LaCava; T L Paquette; J C Beard; B J Wallum; D Porte
Journal:  Diabetologia       Date:  1987-09       Impact factor: 10.122

4.  Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus.

Authors:  M F Saad; S E Kahn; R G Nelson; D J Pettitt; W C Knowler; M W Schwartz; S Kowalyk; P H Bennett; D Porte
Journal:  J Clin Endocrinol Metab       Date:  1990-05       Impact factor: 5.958

5.  Insulin deficiency in non-insulin-dependent diabetes.

Authors:  R C Temple; C A Carrington; S D Luzio; D R Owens; A E Schneider; W J Sobey; C N Hales
Journal:  Lancet       Date:  1989-02-11       Impact factor: 79.321

6.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

7.  Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects.

Authors:  K S Polonsky; B D Given; E Van Cauter
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

8.  Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus.

Authors:  K S Polonsky; B D Given; L J Hirsch; H Tillil; E T Shapiro; C Beebe; B H Frank; J A Galloway; E Van Cauter
Journal:  N Engl J Med       Date:  1988-05-12       Impact factor: 91.245

9.  Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes.

Authors:  S O'Rahilly; R C Turner; D R Matthews
Journal:  N Engl J Med       Date:  1988-05-12       Impact factor: 91.245

10.  Oscillations in insulin secretion during constant glucose infusion in normal man: relationship to changes in plasma glucose.

Authors:  E T Shapiro; H Tillil; K S Polonsky; V S Fang; A H Rubenstein; E Van Cauter
Journal:  J Clin Endocrinol Metab       Date:  1988-08       Impact factor: 5.958

View more
  23 in total

Review 1.  Interactions between insulin resistance and insulin secretion in the development of glucose intolerance.

Authors:  M K Cavaghan; D A Ehrmann; K S Polonsky
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 2.  The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality.

Authors:  S E Kahn; S Zraika; K M Utzschneider; R L Hull
Journal:  Diabetologia       Date:  2009-03-27       Impact factor: 10.122

Review 3.  Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes.

Authors:  Leslie S Satin; Peter C Butler; Joon Ha; Arthur S Sherman
Journal:  Mol Aspects Med       Date:  2015-01-28

4.  Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance.

Authors:  H Larsson; B Ahrén
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

Review 5.  Review of methods for measuring β-cell function: Design considerations from the Restoring Insulin Secretion (RISE) Consortium.

Authors:  Tamara S Hannon; Steven E Kahn; Kristina M Utzschneider; Thomas A Buchanan; Kristen J Nadeau; Philip S Zeitler; David A Ehrmann; Silva A Arslanian; Sonia Caprio; Sharon L Edelstein; Peter J Savage; Kieren J Mather
Journal:  Diabetes Obes Metab       Date:  2017-06-22       Impact factor: 6.577

6.  24-hour glucose profiles during continuous or oscillatory insulin infusion. Demonstration of the functional significance of ultradian insulin oscillations.

Authors:  J Sturis; A J Scheen; R Leproult; K S Polonsky; E van Cauter
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

Review 7.  Age-Related Changes in Glucose Metabolism, Hyperglycemia, and Cardiovascular Risk.

Authors:  Chee W Chia; Josephine M Egan; Luigi Ferrucci
Journal:  Circ Res       Date:  2018-09-14       Impact factor: 17.367

Review 8.  Methods for Measuring Risk for Type 2 Diabetes in Youth: the Oral Glucose Tolerance Test (OGTT).

Authors:  Melinda E Chen; Rebecca S Aguirre; Tamara S Hannon
Journal:  Curr Diab Rep       Date:  2018-06-16       Impact factor: 4.810

Review 9.  Diabetes and altered glucose metabolism with aging.

Authors:  Rita Rastogi Kalyani; Josephine M Egan
Journal:  Endocrinol Metab Clin North Am       Date:  2013-03-22       Impact factor: 4.741

Review 10.  Beta-cell failure in the pathogenesis of type 2 diabetes mellitus.

Authors:  Jeanne H Steppel; Edward S Horton
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.